PositiveID Corporation (OTCQB: PSID)

PositiveID Corporation (OTCQB: PSID)

PositiveID Corporation™ provides advanced biological detection and diagnostic solutions for homeland security and global healthcare needs.

PositiveID Corporation™ (OTCQB: PSID) is an emerging growth company and developer of biological detection and diagnostic systems for America’s homeland defense and the global healthcare market. PositiveID specializes in the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats and outbreaks, whether airborne, in a healthcare setting, or at the point of need.

The Microfluidics-based Bioagent Networked Detector (M-BAND) developed by PositiveID is a bioaerosol monitor with fully integrated systems with sample collection, processing and detection modules. Each module is fully functional and adaptable. M-BAND runs autonomously for up to 30 days, continuously analyzing air samples for the detection of bacteria, viruses, and toxins with results in as little as two hours. Results from individual instruments are reported via a secure wireless network in real time to give an accurate and up to date status for fielded instruments in aggregate.

The company has implemented its own biological assays. More http://www.psidcorp.com/our-products/m-band

PositiveID is taking advantage of state-of-the-art device and diagnostic technologies to develop the Firefly Dx detection system. The system is a two-part device consisting of a portable handheld instrument with wireless Bluetooth communication and disposable single-use cartridges containing all necessary analytical elements. More http://www.psidcorp.com/our-products/firefly-dx

The Caregiver® thermometer by Thermomedics Inc. is the world’s first non-contact device with TouchFree™ technology developed by the team that invented tympanic thermometry! THE CAREGIVER® PROFESSIONAL is a clinical-grade infrared thermometer for measurement of forehead temperature in adults, children, and infants without contact. It is designed for use in a wide variation of medical settings and can also deliver ambient/skin surface temperatures with the flick of a switch.

Value Proposition

Company Highlights

Market Info

Market Value: $11,203,105 a/o Oct 30, 2015
Authorized Shares: 1,970,000,000 a/o Jun 05, 2015
Outstanding Shares: 350,097,044 a/o Aug 07, 2015
Float: 265,892,298 a/o Jun 05, 2015
Shareholders of Record: 76 a/o Jun 05, 2015
Short Interest: 4,809 (5,625%) Sep 30, 2015
Transfer Agent: VStock Transfer LLC

Key Executives

William J. Caragol – Chairman, Chief Executive Officer, Acting Chief Financial Officer
Lyle L. Probst – President
Allison Tomek – Senior Vice President Corporate Development
Kimothy Smith, DVM, Ph.D. – Chief Technology Advisor

PositiveID Corporation
1690 South Congress Avenue
Suite 201
Delray Beach, Florida 33445
Ph: (561) 805-8000
Fax: (561) 805-8001